Company Profile

Quorum Innovations LLC
Profile last edited on: 9/27/23      CAGE: 7FH76      UEI: YECVNVBQP2U1

Business Identifier: Develoment of human microbiome therapeutics
Year Founded
2011
First Award
2021
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2088 Hawthorne Street
Sarasota, FL 34239
   (941) 350-5356
   N/A
   www.quoruminnovations.com
Location: Single
Congr. District: 17
County: Sarasota

Public Profile

Quorum Innovations, LLC is an early stage biopharmaceutical company developing first-in-class immunomodulators for chronic medical conditions. Human microbiome-derived Quorum Probiomic therapeutics have the potential to change human health and disease treatment paradigms unlike any other therapeutic on the market today.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
25-49

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1685969207 2 DARPA $1,249,033
Project Title: Anti-Adhesive Protein for Human Respiratory Surface Defense Against Respiratory Viruses and Pathogens

Key People / Management

  Nick Monsul -- CEO and Co-Founder

  Eva A Berkes

  Karol Gliniewicz -- Senior Scientist

  Jonathan Hensel -- Research Project Manager

Company News

There are no news available.